Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP182935.RAgbh1X4-lPf1-3TR23q8FkGZs68tCX4wpps7ePW6pCUs130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP182935.RAgbh1X4-lPf1-3TR23q8FkGZs68tCX4wpps7ePW6pCUs130_assertion type Assertion NP182935.RAgbh1X4-lPf1-3TR23q8FkGZs68tCX4wpps7ePW6pCUs130_head.
- NP182935.RAgbh1X4-lPf1-3TR23q8FkGZs68tCX4wpps7ePW6pCUs130_assertion description "[Up-regulated miR-21 expression was associated with lymph node positivity (P=0.01), higher proliferation index (ki67>10%) (P=0.03) and advanced breast cancer TNM clinical stage (P=0.021).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP182935.RAgbh1X4-lPf1-3TR23q8FkGZs68tCX4wpps7ePW6pCUs130_provenance.
- NP182935.RAgbh1X4-lPf1-3TR23q8FkGZs68tCX4wpps7ePW6pCUs130_assertion evidence source_evidence_literature NP182935.RAgbh1X4-lPf1-3TR23q8FkGZs68tCX4wpps7ePW6pCUs130_provenance.
- NP182935.RAgbh1X4-lPf1-3TR23q8FkGZs68tCX4wpps7ePW6pCUs130_assertion SIO_000772 19212625 NP182935.RAgbh1X4-lPf1-3TR23q8FkGZs68tCX4wpps7ePW6pCUs130_provenance.
- NP182935.RAgbh1X4-lPf1-3TR23q8FkGZs68tCX4wpps7ePW6pCUs130_assertion wasDerivedFrom befree-20140225 NP182935.RAgbh1X4-lPf1-3TR23q8FkGZs68tCX4wpps7ePW6pCUs130_provenance.
- NP182935.RAgbh1X4-lPf1-3TR23q8FkGZs68tCX4wpps7ePW6pCUs130_assertion wasGeneratedBy ECO_0000203 NP182935.RAgbh1X4-lPf1-3TR23q8FkGZs68tCX4wpps7ePW6pCUs130_provenance.